z-logo
Premium
Neuropeptide Y, B‐type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein‐α
Author(s) -
Keane Fiona M.,
Nadvi Naveed A.,
Yao TsunWen,
Gorrell Mark D.
Publication year - 2011
Publication title -
the febs journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 204
eISSN - 1742-4658
pISSN - 1742-464X
DOI - 10.1111/j.1742-4658.2011.08051.x
Subject(s) - dipeptidyl peptidase , fibroblast activation protein, alpha , peptide yy , dipeptidyl peptidase 4 , chemistry , peptide , endopeptidase , oligopeptidase , biochemistry , neprilysin , neuropeptide y receptor , endocrinology , medicine , neuropeptide , enzyme , biology , receptor , cancer , diabetes mellitus , type 2 diabetes
Fibroblast activation protein‐α (FAP) is a cell surface‐expressed and soluble enzyme of the prolyl oligopeptidase family, which includes dipeptidyl peptidase 4 (DPP4). FAP is not generally expressed in normal adult tissues, but is found at high levels in activated myofibroblasts and hepatic stellate cells in fibrosis and in stromal fibroblasts of epithelial tumours. FAP possesses a rare catalytic activity, hydrolysis of the post‐proline bond two or more residues from the N‐terminus of target substrates. α 2 ‐antiplasmin is an important physiological substrate of FAP endopeptidase activity. This study reports the first natural substrates of FAP dipeptidyl peptidase activity. Neuropeptide Y, B‐type natriuretic peptide, substance P and peptide YY were the most efficiently hydrolysed substrates and the first hormone substrates of FAP to be identified. In addition, FAP slowly hydrolysed other hormone peptides, such as the incretins glucagon‐like peptide‐1 and glucose‐dependent insulinotropic peptide, which are efficient DPP4 substrates. FAP showed negligible or no hydrolysis of eight chemokines that are readily hydrolysed by DPP4. This novel identification of FAP substrates furthers our understanding of this unique protease by indicating potential roles in cardiac function and neurobiology. Structured digital abstract•   FAP   cleaves   GLP‐1‐amide by protease assay   (View interaction)•   DPP4   cleaves   PACAP by protease assay   (View interaction)•   FAP   cleaves   PYY by protease assay   (View interaction)•   FAP   cleaves   NPY by protease assay   (View interaction)•   DPP4   cleaves   Substance P by protease assay   (View interaction)•   DPP4   cleaves   GIP by protease assay   (View interaction)•   DPP4   cleaves   CCL11‐Eotaxin by protease assay   (View interaction)•   DPP4   cleaves   GLP‐1‐amide by protease assay   (View interaction)•   DPP4   cleaves   CXCL12‐SDF1 by protease assay   (View interaction)•   FAP   cleaves   GRF by protease assay   (View interaction)•   FAP   cleaves   GLP‐2 by protease assay   (View interaction)•   DPP4   cleaves   Glucagon by protease assay   (View interaction)•   FAP   cleaves   BNP by protease assay   (View interaction)•   DPP4   cleaves   CXCL2‐GRO by protease assay   (View interaction)•   DPP4   cleaves   CCL22‐MDC by protease assay   (View interaction)•   DPP4   cleaves   CXCL9‐MIG by protease assay   (View interaction)•   FAP   cleaves   GIP by protease assay   (View interaction)•   DPP4   cleaves   GRF by protease assay   (View interaction)•   DPP4   cleaves   CXCL11 ITAC  by protease assay   (View interaction)•   FAP   cleaves   Substance P by protease assay   (View interaction)•   DPP4   cleaves   VIP by protease assay   (View interaction)•   DPP4   cleaves   CCL5 ‐RANTES by protease assay   (View interaction)•   DPP4   cleaves   PHM by protease assay   (View interaction)•   DPP4   cleaves   Oxyntomodulin by protease assay   (View interaction)•   DPP4   cleaves   CXCL10‐IP10 by protease assay   (View interaction)•   DPP4   cleaves   PYY by protease assay   (View interaction)•   DPP4   cleaves   BNP by protease assay   (View interaction)•   DPP4   cleaves   GLP‐2 by protease assay   (View interaction)•   DPP4   cleaves   NPY by protease assay   (View interaction)•   FAP   cleaves   PHM by protease assay   (View interaction)

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here